A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-17

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For caregivers in the Bronx, the pandemic has caused unprecedented psychological distress; in addition to combating social determinants of health (SDOH), these families now face greater financial insecurity and challenges related to their school-aged children. Furthermore, social distancing requirements and limited telehealth resources for Bronx families have posed greater barriers to healthcare. Such parental distress contributes to heightened risk of transgenerational cycles of psychological stress, trauma and maltreatment. The social and economic impacts of the COVID-19 pandemic have had significant consequences for family well-being, putting parents at higher risk of experiencing distress and potentially impairing their ability to provide supportive care to their children. Although children may be less susceptible to the most damaging physical consequences of COVID-19, there are growing concerns regarding the short-and long-term impacts of pandemic-related stressors on children. The marked upheaval of family life over an extended period may make children vulnerable to mental health consequences associated with the public health crisis and infection mitigation efforts. School and childcare closures, unstable financial circumstances, social isolation and lack of support have a disproportionate, cumulative impact on parents and may undermine their capacities to provide support for their children. Importantly, a large body of evidence suggests that parental stress during times of disasters induces psychopathologies in family members including children. Further, high anxiety and depressive symptoms in parents during the pandemic have been associated with higher child abuse potential, whereas greater parental support was associated with lower perceived stress and child abuse potential. In addition to psychological impacts, stress associated with caregiving can interfere with parents' ability to maintain their own health. This multimodal study addresses key strategies to mitigate the psychological and health impact of COVID-19 in parents.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children

NCT05639465

Emotional Distress Prosocial Behavior Pandemic, COVID-19 +2 more

RECRUITING NA

CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment

NCT04431856

Anxiety Depression Traumatic Stress Disorder

COMPLETED NA

Family Intervention to Improve Maternal and Child Mental Health

NCT04700059

Adolescent Pregnancy

UNKNOWN NA

Step 1: Be Aware, Anxiety Prevention Intervention

NCT07044752

Moderate Anxiety

ENROLLING_BY_INVITATION NA

ParentCorps: Promoting Healthy Development in Children From Low Income Communities

NCT01670227

Behavior Problems of Childhood and Adolescence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design

1. Objectives The study team hypothesizes that both the CARE program and the Valera Health app will mitigate the psychological effects of COVID-19 while enhancing access to healthcare in the Bronx. The study will take place at Montefiore Medical Center (MMC), the largest health system in the Bronx, serving predominantly racial and ethnic minority individuals from underserved families. This study will focus on three vulnerable caregiver cohorts presenting with moderate stress: a) caregivers of children with psychiatric conditions (N=130); b) caregivers of children with autoimmune illnesses (N=130); c) caregivers who are frontline healthcare workers at MMC (N=130). While the latter may have more favorable SDOH than families treated at MMC, this cohort has faced unprecedented stress during the pandemic. A randomized controlled trial (RCT) (Stage III, NIH model) with 3 arms will test the study hypothesis: a) CARE program alone; b) Valera Health app; and c) CARE program and Valera Health app. Study procedures will include phone screen to assess eligibility, and surveys at four timepoints: (at study enrollment, 6-, 12- and 24-weeks) will assess parental stress, reflective functioning (RF), barriers to access to healthcare, mood and anxiety symptoms, suicidality (safety) and additional parent and child clinical measures. Smartphones and connectivity will be provided as needed.

Aim 1. To examine the efficacy of the 12-week CARE program on caregivers' emotional health and RF. Hyp. 1: (a) Compared to the Valera Health app arm at 12- and 24-week follow-up, participation in the CARE program will result in decreased caregiver's perceived stress, increased RF, and improved caregiver's mood and anxiety symptoms. (b) Therapeutic improvements in Hypothesis 1a will be mediated by RF, as it reflects mentalizing capacity.

Aim 2: To examine the efficacy of the 12-week Valera Health app on caregivers' emotional health and access to healthcare. Hypothesis 2: (a), The Valera Health app, will result in decreased caregiver's perceived stress, increased access to healthcare, and increased adherence to and engagement in treatment. (b) CARE program + Valera Health app arm will be superior to CARE or Valera Health app alone on all outcome measures.

Exploratory Aim: (a) The study will also explore the effects on outcome of providing technology and connectivity to families who lack them during the study period. (b) The relative effectiveness of the intervention among the 3 vulnerable cohorts will be explored. (c) Machine learning approaches to explore complex patterns as predictors of outcome including COVID-19 illness/deaths, medical comorbidity, psychopathology, housing, poverty, children's school status, age, family functioning, and trauma, will be utilized.
2. Study Timelines

Individual Subject Timeline:

Participation in this research will last about 24 weeks. Participants will partake in 12 one-hour group sessions that meet once per week. Participants will complete several surveys when enrolled in the study and then after 6 weeks, after 12 weeks, and after 24 weeks.

Overall Timeline:

Because Investigators intend to rely on a pre-existing clinical infrastructure, Investigators anticipate being able to begin enrollment within the first six months of the study. Participants will return for 6-month follow-ups. Data analysis will occur throughout the duration of the study, along with publications and conference presentations. The likelihood that this study will be carried out as planned is very high, as all methods and collaborations are already in place.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parenting Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

3 interventions: Care \& Valera, Care only, and Valera only.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parents of children receiving mental health treatment at Montefiore

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app .

Group Type EXPERIMENTAL

CARE Program and Valera Application with care manager functionality

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials as well as the ability to connect to their child's treatment team via care manager.

Valera Application with care manager functionality

Intervention Type BEHAVIORAL

Participant will receive the Valera health application which will provide parent education materials and the ability to connect to their child's treatment team via care manger.

CARE Program

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program.

Parents of children being treated for autoimmune disorders at Montefiore

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.

Group Type EXPERIMENTAL

CARE Program and Valera Application with care manager functionality

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials as well as the ability to connect to their child's treatment team via care manager.

Valera Application with care manager functionality

Intervention Type BEHAVIORAL

Participant will receive the Valera health application which will provide parent education materials and the ability to connect to their child's treatment team via care manger.

CARE Program

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program.

Healthcare workers at Montefiore

Participants will either CARE program alone; b) Valera Health app; c) CARE program and Valera Health app.

Group Type EXPERIMENTAL

CARE Program

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program.

Valera Application

Intervention Type BEHAVIORAL

Participant will receive the Valera health application which will provide parent education materials.

CARE Program and Valera Application

Intervention Type BEHAVIORAL

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CARE Program and Valera Application with care manager functionality

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials as well as the ability to connect to their child's treatment team via care manager.

Intervention Type BEHAVIORAL

Valera Application with care manager functionality

Participant will receive the Valera health application which will provide parent education materials and the ability to connect to their child's treatment team via care manger.

Intervention Type BEHAVIORAL

CARE Program

Participant will take part in 12 week CARE program.

Intervention Type BEHAVIORAL

Valera Application

Participant will receive the Valera health application which will provide parent education materials.

Intervention Type BEHAVIORAL

CARE Program and Valera Application

Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All participants will be primary caregivers who present with moderate level of stress by meeting a severity score of ≥ 14 on the Perceived Stress Scale (PSS)
* Investigators will allow primary caregivers (e.g., grandmothers and aunts) as it is common in the patient population
* Clinical cohorts will be active patients in the psychiatric and rheumatology clinics in Montefiore Medical Center (MMC)
* Frontline health care providers will be those who are required to work on site at Montefiore Medical Center (MMC)

Exclusion Criteria

* Serious psychiatric or substance use difficulty that, in the judgement of the PI, would preclude meaningful participation in a parent intervention
* Active child abuse/maltreatment cases
* Neurocognitive conditions that may prevent participants from accessing telehealth services
* Primary language other than Spanish or English
* Use of the Valera Health app or a smartphone health platform similar to the Valera app

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No